Novel role of the antimicrobial peptide LL-37 in the protection of neutrophil extracellular traps against degradation by bacterial nucleases
Neumann A., et al. Novel role of the antimicrobial peptide LL-37 in the protection of neutrophil extracellular traps against degradation by bacterial nucleases. J. Innate Immun. 2014, 6:860-868.
The antimicrobial activity of the cathelicidin LL37 is inhibited by F-actin bundles and restored by gelsolin
Weiner D.J., et al. The antimicrobial activity of the cathelicidin LL37 is inhibited by F-actin bundles and restored by gelsolin. Am. J. Respir. Cell Mol. Biol. 2003, 28:738-745.
Nuclease expression by Staphylococcus aureus facilitates escape from neutrophil extracellular traps
Berends E.T.M., et al. Nuclease expression by Staphylococcus aureus facilitates escape from neutrophil extracellular traps. J. Innate Immun. 2010, 2:576-586.
Comparative activity of garenoxacin and other agents by susceptibility and time-kill testing against Staphylococcus aureus, Streptococcus pyogenes and respiratory pathogens
Noviello S., et al. Comparative activity of garenoxacin and other agents by susceptibility and time-kill testing against Staphylococcus aureus, Streptococcus pyogenes and respiratory pathogens. J. Antimicrob. Chemother. 2003, 52:869-872.
Antibodies mediate the formation of neutrophil extracellular traps (NETs) in the middle ear and facilitate secondary pneumococcal otitis media
Short K.R., et al. Antibodies mediate the formation of neutrophil extracellular traps (NETs) in the middle ear and facilitate secondary pneumococcal otitis media. Infect. Immun. 2014, 81:364-370.
Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis
Hakkim A., et al. Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:9813-9818.